Barclays’s PDS Biotechnology PDSB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1
| Closed | – | – | 4407 |
|
|
2024
Q2 | $0 | Sell |
1
-19,765
| -100% | – | ﹤0.01% | 4282 |
|
|
2024
Q1 | $78K | Sell |
19,766
-18,636
| -49% | -$73.5K | ﹤0.01% | 3722 |
|
|
2023
Q4 | $191K | Buy |
38,402
+33,488
| +681% | +$167K | ﹤0.01% | 3526 |
|
|
2023
Q3 | $25K | Sell |
4,914
-657
| -12% | -$3.34K | ﹤0.01% | 3849 |
|
|
2023
Q2 | $28K | Sell |
5,571
-33,684
| -86% | -$169K | ﹤0.01% | 3901 |
|
|
2023
Q1 | $241K | Buy |
+39,255
| New | +$241K | ﹤0.01% | 3042 |
|
|
2021
Q4 | – | Sell |
-14,728
| Closed | -$219K | – | 3667 |
|
|
2021
Q3 | $219K | Buy |
+14,728
| New | +$219K | ﹤0.01% | 2937 |
|
|
2020
Q3 | – | Sell |
-37
| Closed | – | – | 3867 |
|
|
2020
Q2 | $0 | Buy |
+37
| New | – | ﹤0.01% | 3911 |
|
|
2019
Q4 | – | Sell |
-1
| Closed | – | – | 4135 |
|
|
2019
Q3 | $0 | Buy |
+1
| New | – | ﹤0.01% | 4338 |
|
|
2018
Q2 | – | Sell |
-219
| Closed | -$5K | – | 4325 |
|
|
2018
Q1 | $5K | Buy |
219
+57
| +35% | +$1.3K | ﹤0.01% | 4022 |
|
|
2017
Q4 | $31K | Buy |
162
+139
| +604% | +$26.6K | ﹤0.01% | 3540 |
|
|
2017
Q3 | $5K | Buy |
23
+7
| +44% | +$1.52K | ﹤0.01% | 3655 |
|
|
2017
Q2 | $3K | Buy |
16
+12
| +300% | +$2.25K | ﹤0.01% | 3631 |
|
|
2017
Q1 | $1K | Sell |
4
-16
| -80% | -$4K | ﹤0.01% | 3896 |
|
|
2016
Q4 | $5K | Buy |
20
+15
| +300% | +$3.75K | ﹤0.01% | 3438 |
|
|
2016
Q3 | $1K | Sell |
5
-194
| -97% | -$38.8K | ﹤0.01% | 3764 |
|
|
2016
Q2 | $40K | Buy |
+199
| New | +$40K | ﹤0.01% | 2643 |
|
|
2016
Q1 | – | Sell |
-6
| Closed | -$1K | – | 3616 |
|
|
2015
Q4 | $1K | Buy |
+6
| New | +$1K | ﹤0.01% | 3106 |
|